Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Emerald Health Therapeutics Inc (EMH.VN)

Emerald Health Therapeutics Inc (EMH.VN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 74,721
  • Shares Outstanding, K 149,443
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta 2.06
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.38
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.16
  • Most Recent Earnings 0.00 on 06/30/19
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

    TSX Bottom 100 Stocks

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/19
See More
  • Average Estimate -0.05
  • Number of Estimates 1
  • High Estimate -0.05
  • Low Estimate -0.05
  • Prior Year N/A
  • Growth Rate Est. (year over year) -100.01%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.385 +19.48%
on 11/18/19
0.940 -51.06%
on 10/23/19
-0.450 (-49.45%)
since 10/22/19
3-Month
0.385 +19.48%
on 11/18/19
2.010 -77.11%
on 08/26/19
-1.500 (-76.53%)
since 08/22/19
52-Week
0.385 +19.48%
on 11/18/19
4.660 -90.13%
on 03/20/19
-3.240 (-87.57%)
since 11/22/18

Most Recent Stories

More News
Emerald Health Therapeutics Responds to Inaccurate Allegations by Village Farms

Emerald Health Therapeutics, Inc. ("Emerald") (TSXV: EMH; OTCQX: EMHTF) today responded to inaccurate allegations made by Village Farms International, Inc. ("Village Farms") (TSX: VFF; Nasdaq: VFF) in...

EMHTF : 0.3401 (-10.50%)
EMH.VN : 0.458 (-8.40%)
VLLFF : 2.4000 (unch)
Cannabis Offers Patients Reprieve from Big Pharma Players

Big pharma has been under intense scrutiny after millions have claimed that the industry is out to seek profits instead of supporting the livelihoods of its patients. According to a study published in...

SCQBD : 0.7420 (+1.08%)
JTBK : 0.1000 (+25.00%)
TGODF : 0.7448 (-15.84%)
TGOD.TO : 0.99 (-15.38%)
MRMD : 0.8651 (+1.78%)
EMHTF : 0.3401 (-10.50%)
EMH.VN : 0.458 (-8.40%)
LHSIF : 0.4268 (-4.45%)
LHS.CN : 0.570 (-5.00%)
Emerald Health Therapeutics' Pure Sunfarms JV Records Q3 Net Sales of $24.0 Million, 69% Gross Margin, 56% EBITDA Margin, Fourth Consecutive Quarter of Positive EBITDA, and $0.63/gram All-in Production Cost

Pure Sunfarms is #1 dried flower brand with Ontario Cannabis Store in October, with 16% market share and #1 selling product

EMHTF : 0.3401 (-10.50%)
EMH.VN : 0.458 (-8.40%)
Spending on Cannabis Continues to Grow in Legalized Regions

Due to various recent regulatory changes, the cannabis industry is slowly evolving out of the black market and morphing into a global economic powerhouse. While cannabis still remains heavily regulated...

CRFTF : 0.0884 (-15.16%)
CRFT.CN : 0.120 (-7.69%)
HEXO : 2.19 (-13.78%)
HEXO.TO : 2.96 (-12.68%)
OGI : 2.63 (-8.04%)
OGI.TO : 3.53 (-7.83%)
TGODF : 0.7448 (-15.84%)
TGOD.TO : 0.99 (-15.38%)
EMHTF : 0.3401 (-10.50%)
EMH.VN : 0.458 (-8.40%)
Emerald Health Therapeutics Announces $2.5 Million Prospectus Sale and Concurrent Secondary Sale

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE OR FOR DISSEMINATION IN THE UNITED STATES

EMHTF : 0.3401 (-10.50%)
EMH.VN : 0.458 (-8.40%)
CBD's Medical Applications Remain Key to its Rapid Market Growth

The evolution of the cannabis industry has introduced new products into the marketplace, causing the sales and market share of flower to dwindle. Normally, most people associate cannabis with its counter-culture,...

SCQBD : 0.7420 (+1.08%)
NLBIF : 0.3150 (+5.85%)
NLB.CN : 0.395 (+1.28%)
NBEV : 2.27 (-4.22%)
EMHTF : 0.3401 (-10.50%)
EMH.VN : 0.458 (-8.40%)
LHSIF : 0.4268 (-4.45%)
LHS.CN : 0.570 (-5.00%)
TRTC : 0.2170 (-0.14%)
Emerald Health Therapeutics Receives Organic Certification for Greenhouse and Outdoor Metro Vancouver Operation

Emerald Health Therapeutics, Inc. ("Emerald") (TSXV: EMH; OTCQX: EMHTF) has received organic certification for cannabis production at its Metro Vancouver operation in British Columbia, which encompasses...

EMHTF : 0.3401 (-10.50%)
EMH.VN : 0.458 (-8.40%)
Novel CBD-Based Products Capture the Attention of Discerning Consumers

As the cannabis industry continues growing, associations about the plant's use are rapidly beginning to change. Additionally, the way people consuming cannabis is also changing. While not as grand, cannabis...

SDEC : 0.0710 (-10.13%)
NBEV : 2.27 (-4.22%)
MMNFF : 0.6050 (-7.25%)
MMEN.CN : 0.800 (-3.61%)
EMHTF : 0.3401 (-10.50%)
EMH.VN : 0.458 (-8.40%)
TRTC : 0.2170 (-0.14%)
Emerald Health Therapeutics to Supply STENOCARE with Medical Cannabis Products for Denmark

Emerald Health Therapeutics, Inc. ("Emerald") (TSXV: EMH; OTCQX: EMHTF) has signed an agreement to become a new supplier to STENOCARE A/S ("STENOCARE") of medical cannabis for Denmark and STENOCARE's international...

EMHTF : 0.3401 (-10.50%)
EMH.VN : 0.458 (-8.40%)
Patients Turn to CBD for Comfort as Access Becomes More Widespread

Anxiety disorders are one of the most common mental illnesses in the U.S., affecting nearly 40 million adults, according to the Anxiety and Depression Association of America. Anxiety disorders are highly...

SCQBD : 0.7420 (+1.08%)
SDEC : 0.0710 (-10.13%)
HEXO : 2.19 (-13.78%)
HEXO.TO : 2.96 (-12.68%)
OGI : 2.63 (-8.04%)
OGI.TO : 3.53 (-7.83%)
EMHTF : 0.3401 (-10.50%)
EMH.VN : 0.458 (-8.40%)
LHSIF : 0.4268 (-4.45%)
LHS.CN : 0.570 (-5.00%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

The current trending strength of the market is Maximum.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Key Turning Points

2nd Resistance Point 0.580
1st Resistance Point 0.540
Last Price 0.458
1st Support Level 0.460
2nd Support Level 0.420

See More

52-Week High 4.660
Fibonacci 61.8% 3.027
Fibonacci 50% 2.523
Fibonacci 38.2% 2.018
Last Price 0.458
52-Week Low 0.385

See More

Business Summary

Emerald Health Therapeutics Inc is a vertically integrated Canadian licensed producer of cannabis, focused on developing proprietary, cannabis products for medical and adult-use customers. The company's Pure Sunfarms joint venture has two 1.1 M sf greenhouses. The Verdelite operation in Quebec is an...

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar